Orchard Therapeutics Ltd has come closer to its goal of becoming a global supplier of gene therapies following an agreement with GlaxoSmithKline Plc to take over that company’s portfolio of gene therapies for rare diseases. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
